Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Influence of Acetic Acid on a Pap smear of Dysplastic Lesion

FRIEDERIKE HOELLEN, MICHAEL K. BOHLMANN, JOACHIM BRADE, ACHIM RODY, KLAUS DIEDRICH, WOLF-DIEDRICH HUSSTEDT and AMADEUS HORNEMANN
Anticancer Research March 2013, 33 (3) 1125-1130;
FRIEDERIKE HOELLEN
1Department of Gynecology and Obstetrics, University of Schleswig-Holstein, Luebeck Campus, Luebeck, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: friederike.hoellen@uksh.de
MICHAEL K. BOHLMANN
1Department of Gynecology and Obstetrics, University of Schleswig-Holstein, Luebeck Campus, Luebeck, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JOACHIM BRADE
2Institute for Biomedical Statistics, University Medical Centre Mannheim, University of Heidelberg, Mannheim, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ACHIM RODY
1Department of Gynecology and Obstetrics, University of Schleswig-Holstein, Luebeck Campus, Luebeck, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KLAUS DIEDRICH
1Department of Gynecology and Obstetrics, University of Schleswig-Holstein, Luebeck Campus, Luebeck, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
WOLF-DIEDRICH HUSSTEDT
1Department of Gynecology and Obstetrics, University of Schleswig-Holstein, Luebeck Campus, Luebeck, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
AMADEUS HORNEMANN
3Department of Obstetrics and Gynecology, University Medical Centre Mannheim, University of Heidelberg, Mannheim, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background: Cervical cancer prevention is performed by taking Pap smears. The correct execution of the smear is crucial as an inadequate smear might result in underdiagnosis. The second means of cervical cancer prevention is visual inspection of the cervix uteri with acetic acid, while often both methods are combined. We investigated whether the application of acetic acid compromises the Pap smear. Patients and Methods: A total of 100 patients with dysplasia were prospectively included; Pap smears were obtained before and after the application of acetic acid. Results: We observed an alteration of the result of the Pap smear after acetic acid application in 41%. However, these alterations did not result in a dysplastic case being classed as a normal smear or vice versa. Conclusion: The application of acetic acid to the transformation zone of the cervix uteri may enhance changes of the Pap smear in dysplasia, however, the changes affect subgroups of dysplasia and thus do not change therapeutic management.

  • Pap smear
  • acetic acid
  • dysplasia
  • colposcopy
  • cervical cancer

Cervical cancer is responsible for approximately 275,000 deaths per year worldwide (1). As 85% of the approximately 530,000 annually new-diagnosed cases of cervical cancer occur in developing countries (2), emphasis has to be placed on cheap screening methods with high sensitivity (3).

After the introduction of special screening programs in a multitude of countries, the incidence of invasive cervical cancer decreased significantly, and mortality due to cervical cancer was reduced by 40 to 90% about one decade ago (3-6). In the U.S. in 2005, 98% of women reported ever having a Pap smear, 90% reported having had a recent Pap smear (within three years), and 84% were adherent to U.S. Preventive Services Task Force (USPSTF) screening (7). In industrialized countries, screening is performed by an individual combination of visual inspection with acetic acid (VIA) cytology, histology, colposcopy and human papilloma virus (HPV) tests (8, 9). In particular,emphasis has to be placed on VIA for its high sensitivity in comparison to the Pap smear (10), cytology (11) and colposcopy (8, 12). The Papanicolaou test has low sensitivity but high specificity, whereas visual detection methods have a high sensitivity in addition to being cheaper (13-15). The established method for cytological diagnosis was first described in 1942 by George Papanicolaou (16) who soon introduced it for the diagnosis of uterine dysplasia and cancer (17) and thus pioneered cancer secondary prevention. In 1971, the so called Pap smear method for diagnosing cervical dysplasia was introduced as a procedure paid by health insurance companies once a year for women over 19 years of age in Germany. The average annual participation rate in Germany is about 50% and considering a 3-year interval, which constitutes the usual screening sequence in many other European countries, the coverage reaches about 80% (18). But despite standardized screening methods, preventive intervention, and short intervals between the examinations, Germany has one of the highest incidence rates of cervical cancer in Western Europe (19). Thus, a strong effort has to be made in order to optimize screening methods. Often a colposcope is used to assess the transformation zone, to take the smear directly and to differentiate a lesion from normal epithelium (12). Today, even experiments with automated image analysis of digital colposcopy for the detection of cervical neoplasia are used (15, 20). The narrow band imaging (NBI) system used in endoscopy can be used to obtain high-contrast vascular images (21). In developing countries, studies have shown that VIA without colposcopy or even without cytology has reasonable results (22). In our hospital, colposcopic findings are still interpreted by a medical doctor. The colposcopic examination usually includes an acetic acid test and sometimes additional Lugol's iodine. Immature metaplastic and dysplastic cervical squamous epithelia turn white after application of acetic acid during the exam. The whitening process occurs visually over several minutes and subjectively helps to discriminate between dysplastic and normal tissue. Acetic acid results in white epithelium if an increased ratio of nuclear material to cytoplasmic volume is present. Acetic acid has a dehydrating effect on cells and accentuates the nuclear/cytoplasmic ratio. Thus, areas with marginally elevated nuclear/cytoplasmic ratios will stand out more. Acetic acid is also mucolytic and assists in cleaning the cervix. The use of acetic acid has been discussed as possibly influencing the results of a Pap smear: Griffiths et al. put forward the idea that diagnostic epithelial cells can be removed or damaged by scraping with a sampling device, by vaginal digital examination, or as a result of application of acetic acid prior to a colposcopic examination (23). A recently published investigation showed that the sequence of acid application and taking a smear in non dysplastic cases did not change the ultimate result (24).

The assessment of the cervix may be limited when the cervix is contaminated e.g. with blood. This is often seen when performing the colposcopy after taking the Pap smear. However, screening procedures lack standard methodical guidelines concerning the sequence of acetic acid application and cytological sample taking. The present study investigated whether the dysplastic Pap smear (class III, IIID, IV and V) (Bethesda correlate Low-grade Squamous Intraepithelial Lesion, LGSIL, and High-grade Intraepithelial Lesion,HGSIL) is altered by acetic acid.

Patients and Methods

Between September 2009 and May 2010, 100 of the patients with dysplasia being referred to our special dysplastic consultation-hour were prospectively included in this investigation. The protocol of the study was approved by the local Review Board (09-141). Only patients who provided written informed consent participated in the study. For every patient, anamnesis was taken and consecutively the cervix was visualized using a bivalve speculum. A colposcopy was then performed. The transformation zone was identified and a Pap smear was taken with a cytobrush. A 5% acetic acid solution was then applied to the transformation zone. Again, a colposcopy was carried out and after 30 sec, a second Pap smear was taken. All of the smears and the colposcopic examinations were performed by the same person. The two smears obtained were fixed directly. After staining, they were examined by an experienced cytologist who analyses all the gynaecological cytology in our hospital. The smears were blinded and the cytologist was not aware of the order in which the respective smears were taken. The smears were classified according to the Münchner Nomenklatur II (25). In 92 of the patients, a tissue sample was taken out of the transformation zone when there was a suspicious area detected.

Statistics. Data (scores before and after application of acid) are presented as frequencies. According to the histological result, the respective ratios (true-positive, false-negative etc.) were computed as accuracy measures. All statistical analyses were performed with SAS (SAS Institute Inc., North Carolina, USA, Version 9.2 July 12, 2011).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table I.

Change of smear grade after acetic acid application.

Results

A total of 100 patients were examined, 200 smears were performed. The patients' median age was 33.6 years (range 19.8-74.5 years). In all patients, the previously detected dysplasia was confirmed in the smear. In 41 patients (41%), the Papanicolaou grade of the Pap smear changed after application of acetic acid (Table I). In five cases it changed from a worse to a better grade of dysplasia (from PAP IVa to PAP IIID), in nine patients from a better to a worse grade (from PAP IIID to PAP IVa) (Table II). In eight patients, the result of the Pap smear changed from a clear moderate dysplasia (PAP IIID) to an unclear grade (PAP III). In 18 patients it changed from the undefined grade PAP III to dysplastic PAP IIID; in one patient from PAP III to IVa. Class PAP III (3) in the Münchner Nomenklatur II means the cells are degenerated or altered by infection. A clear statement about dysplasia for this class is not possible and therefore it is usually recommended to repeat the smear within two weeks or to obtain tissue for a histological evaluation. We additionally present the tissue samples we obtained from 92 of the patients. The histological results with the corresponding smears are shown in Table III. In 29 patients, no dysplasia was found after biopsy. The results were infection, condylomata acuminata, or normal tissue without alterations. Table IV demonstrates the accuracy ratios of the smears and the histological results.

Discussion

Cervical cancer is the second most common female tumor worldwide, and its incidence is disproportionately high (>80%) in the developing world. In the United States, in which Pap tests have reduced the annual incidence to approximately 11,000 cervical cancers, >60% of cases are reported to occur in medically-underserved populations as part of a complex of diseases linked to poverty, race/ethnicity, and/or health disparities (26). Thus, prevention strategies require low costs, practicability and effectiveness at the same time. Cytology presents an economic method for secondary prevention. False-negative results in Pap smears for early detection of the disease therefore have to be as few as possible. Both cervical intraepithelial neoplasia grade I (CIN I) (mild dysplasia) and human papillomavirus (HPV) lesions are grouped together as low-grade squamous intraepithelial lesions (LGSIL), while moderate and severe dysplasia (CIN II and III) belong to the high-grade squamous intraepithelial lesion (HGSIL) category. Atypical squamous cells of undetermined significance (ASCUS) and atypical glandular cells of undetermined significance (AGCUS) need further qualification as to whether they favor a reactive or neoplastic process (27). In most cases, cytological results according to the Münchner Nomenklatur II correspond to analogous histopathological findings. PAP II plus HPV infection corresponds to LGSIL, PAP IIw corresponds to ASCUS, respectively AGCUS when there is an HPV infection, PAP IIID and PAP IV correspond to HGSIL. There is no counterpart for PAP III, which means the cells are degenerated or altered by infection. A statement about dysplasia for this class is not possible and therefore it is usually recommended to repeat the smear within two weeks or to obtain tissue for histological evaluation (28). According to the individual Pap smear and the patient's history, guidelines based on the Bethesda system suggest certain procedures, e.g. either wait and see with examinations at certain intervals, or histopathological diagnostic assessment by cervical conization (27, 29). Thus, misinterpretation of Pap smear due to technical aberration, might lead to redundant operations or inadequate therapy. False-negative Pap smear results can be attributed to several factors. Among the variables are sampling errors, e.g. cell sample collection, and mistakes in transferring cells to slides, laboratory errors, e.g. errors in performing the hematoxylin staining, and interpretation errors, e.g. errors in the individual interpretation by the cytologist (30). Considerable numbers of false-negative Pap smears may occur with the traditional Pap technique, mostly due to sampling errors. More recently, the use of liquid-based technologies such as ThinPrep and AutoCyte Prep have gained popularity, in part because of evidence suggesting a reduction in the incidence of inadequate smears (31-32). Acetic acid has a dehydrating effect on cells and accentuates the nuclear/cytoplasmic ratio. Thus, areas with marginally elevated nuclear/cytoplasmic ratios will stand out more in the colposcopic examination. The principle of VIA consists in these changes in the macroscopic pattern. Thus we hypothesized there might be a change in the microscopic pattern, e.g. in the Pap smear as well, due to changes of the cellular architecture and problems with interpreting the smear because of cell loss or cell damage. Griffiths et al. pointed out the possible advantages of taking smear samples after colposcopy and acetic acid application: first, avoiding possible bleeding induced by scraping with a sampling device, secondly avoiding epithelial cell loss and thirdly taking cytological samplings exactly at the acetowhite suspicious lesions identified by colposcopy (23). The authors found an elevated false-negative rate in post-acetic acid smears of 53% in comparison to 16% in pre-acetic acid smears. For these reasons, it is important to know possible influences on the cytological result. Other agents used in the course of the colposcopic examination have been investigated because they are believed to interfere with Pap tests. There is level I evidence that modest lubrication of the external surface of the speculum does not impair cytological and infectious evaluation of the cervix (33). We demonstrated that prior acetic acid treatment does not influence non-dysplastic Pap smears (24). In the present study, 41% of all Pap smears were clearly altered after acetic acid application. Although the results were not significant, this striking ratio must be further analyzed. In the present study, conspicuous Pap smears were detected, irrespective of the application of acetic acid. Pap smears revealing LGSIL or HGSIL were not changed to normal Pap smears by acetic acid. Thus, the sensitivity of cytology was not altered by prior acetic acid application. Considering the results of the Pap smears and their particular diagnostic and therapeutic consequences, changes can be observed regarding PAP III, PAP IIID and PAP IVa of the Münchner Nomenklatur. A PAP IIID result should be clarified after an interval of three months, whereas a PAP IVa should directly be histologically examined, e.g. a biopsy or conization should be performed. In the present study, we considered the respective prognostically worse smear as the valid result. Thus, when PAP IIID became PAP IVa after application of acetic acid and vice versa, a histological sample was obtained. However, when PAP IIID and PAP IVa are transcribed into the Bethesda classification, both become HGSIL. Thus, there would be no change in diagnostic procedure or therapy if the Bethesda classification were applied (28). On the other hand, we hypothesized that the application of acetic acid might render a smear difficult to analyze and difficult to assign to a certain class of the Münchner Nomenklatur for the pathologist. Thus, the proportion of PAP III, e.g. smears which are suspect, but not clearly analyzable due to disruptive factors such as infections or menstrual blood, was expected to be elevated after application of acetic acid in comparison to native smears. However, only eight smears became PAP III, all of them were native PAP IIID. Neither PAP II nor PAP IVa was changed to PAP III. Interestingly, in contrast, 20 of the PAP III native smears were changed to PAP IIID after the application of acetic acid, e.g. there might even be a better assessment after the application of acetic acid. However, the results of our study are statistically not significant and further study should be performed in order to confirm that there is a better assessment of Pap smears after acetic acid application in comparison to native smears. A total of 23 (25,8%) of the 89 histological samples were non-dysplastic tissue although the Pap smears indicated dysplasia (regardless of acetic acid use). This result is in line with the study by Szurkus et al., who performed loop excisions without a prior biopsy (34). Nevertheless, we should critically evaluate whether the tissue samples were taken from the correct area of the cervical transformation zone in these patients. All these patients were asked to return for another colposcopic examination within three months. Regarding our results presented in Table IV, all smears of the collective were dysplastic according to selection criteria. Therefore all of the dysplastic smears with corresponding non-dysplastic histological results in tissue samples were false-positives. However, these data of false-positives must not be interpreted as quantitative evidence concerning the correlation of dysplasia in smears and biopsies, as the end point of the study aimed at different evidence. The apparent evidence is due to selection criteria and does not reflect any disqualification of the Pap smear as an established diagnostic technique.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table II.

Change of smear after acetic acid application (subgroups).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table III.

Histological results and corresponding smear result.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table IV.

Histological results and accuracy ratios.

Conclusion

Secondary prevention of cervical cancer in medical practice is performed by obtaining cytological smears from the outer cervical os, the Pap smear. In Germany, an examination is performed once a year when there is an inconspicuous result and the Pap smear is classified according to the Münchner Nomenklatur II. In cases of abnormal Pap smears, the patient should be referred for special dysplastic consultation where a colposcopy is performed and, if necessary, a tissue sample is obtained. As the result of the Pap smear provides the basis for further diagnostic proceedings or therapy, a high methodical sensivity is required. The application of acetic acid constitutes a major step in the diagnostic approach when performing a colposcopy, the VIA. The aim of the present study was to investigate whether the application of acetic acid changes the result of the Pap smear, or not. We already demonstrated that acetic acid does not influence non dysplastic Pap smears (24). In the present study, we observed an alteration of the result of the Pap smear after acetic acid in 41%. However, these alterations did not change a dysplastic PAP smear into a normal PAP smear finding nor vice versa. The alterations concerned subclasses (of the Münchner Nomenklatur II) of HGSIL according to the Bethesda classification. After the application of acetic acid there was no impairment of assessment, there were even fewer smears classified as PAP III (unclear grade). The sequence of sample taking and VIA does not seem to influence the diagnostic and therapeutic proceedings based on the result of a Pap smear. In conclusion, the application of diluted acetic acid to the cervix neither enhances the systematic misinterpretation of the Pap smear nor influences the diagnostic accuracy of the smear in correlation to the corresponding histological findings. Further analysis should be performed in order to evaluate whether VIA should even be performed prior to smear taking in order to provide for adequate smear samples.

  • Received December 30, 2012.
  • Revision received February 2, 2013.
  • Accepted February 4, 2013.
  • Copyright© 2013 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

References

  1. ↵
    1. WHO/ICO
    . WHO/ICO information centre on human papilloma virus (HPV) and cervical cancer, 2011.
  2. ↵
    1. Kahesa C,
    2. Kjaer SK,
    3. Ngoma T,
    4. Mwaiselage J,
    5. Dartell M,
    6. Iftner T,
    7. Rasch V
    : Risk factors for VIA positivity and determinants of screening attendances in Dar es Salaam, Tanzania. BMC Public Health 12: 1055, 2012.
    OpenUrlPubMed
  3. ↵
    1. Syrjanen K,
    2. Naud P,
    3. Derchain S,
    4. Roteli-Martins C,
    5. Longatto-Filho A,
    6. Tatti S,
    7. Branca M,
    8. Erzen M,
    9. Hammes LS,
    10. Matos J,
    11. Gontijo R,
    12. Sarian L,
    13. Braganca J,
    14. Arlindo FC,
    15. Maeda MY,
    16. Lorincz A,
    17. Dores GB,
    18. Costa S,
    19. Syrjanen S
    : Comparing PAP smear cytology, aided visual inspection, screening colposcopy, cervicography and HPV testing as optional screening tools in Latin America. Study design and baseline data of the LAMS study. Anticancer Res 25(5): 3469-3480, 2005.
    OpenUrlAbstract/FREE Full Text
    1. Levi F,
    2. Lucchini F,
    3. Negri E,
    4. Franceschi S,
    5. la Vecchia C
    : Cervical cancer mortality in young women in Europe: patterns and trends. Eur J Cancer 36(17): 2266-2271, 2000.
    OpenUrlCrossRefPubMed
    1. Linos A,
    2. Riza E
    : Comparisons of cervical cancer screening programmes in the European Union. Eur J Cancer 36(17): 2260-2265, 2000.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Nygard JF,
    2. Skare GB,
    3. Thoresen SO
    : The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer. J Med Screen 9(2): 86-91, 2002.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    1. Nelson W,
    2. Moser RP,
    3. Gaffey A,
    4. Waldron W
    : Adherence to cervical cancer screening guidelines for U.S. women aged 25-64: data from the 2005 Health Information National Trends Survey (HINTS). J Womens Health 18(11): 1759-1768, 2009.
    OpenUrlCrossRef
  6. ↵
    1. Adamopoulou M,
    2. Kalkani E,
    3. Charvalos E,
    4. Avgoustidis D,
    5. Haidopoulos D,
    6. Yapijakis C
    : Comparison of cytology, colposcopy, HPV typing and biomarker analysis in cervical neoplasia. Anticancer Res 29(8): 3401-3409, 2009.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Hefler L,
    2. Polterauer S,
    3. Nowotny G,
    4. Tempfer C,
    5. Kohlberger P,
    6. Sliutz G,
    7. Speiser P,
    8. Joura E,
    9. Reinthaller A
    : Necessity of colposcopy and biopsy prior to large loop excision of the transformation zone (LLETZ). Anticancer Res 28(1B): 519-521, 2008.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    1. Gaffikin L,
    2. Lauterbach M,
    3. Blumenthal PD
    : Performance of visual inspection with acetic acid for cervical cancer screening: a qualitative summary of evidence to date. Obstet Gynecol Surv 58(8): 543-550, 2003.
    OpenUrlPubMed
  9. ↵
    1. Slawson DC,
    2. Bennett JH,
    3. Herman JM
    : Are Papanicolaou smears enough? Acetic acid washes of the cervix as adjunctive therapy: a HARNET study. Harrisburg Area Research Network. J Fam Pract 35(3): 271-277, 1992.
    OpenUrlPubMed
  10. ↵
    1. Ottaviano M,
    2. La Torre P
    : Examination of the cervix with the naked eye using acetic acid test. Am J Obstet Gynecol 143(2): 139-142, 1982.
    OpenUrlPubMed
  11. ↵
    1. Tempfer C,
    2. Polterauer S,
    3. Grimm C,
    4. Bentz EK,
    5. Reinthaller A,
    6. Hefler LA
    : Endocervical cytobrush for the detection of cervical dysplasia before large loop excision of the transformation zone (LLETZ). Anticancer Res 28(5B): 3131-3134, 2008.
    OpenUrlAbstract/FREE Full Text
    1. Aggarwal P,
    2. Batra S,
    3. Gandhi G,
    4. Zutshi V
    : Comparison of papanicolaou test with visual detection tests in screening for cervical cancer and developing the optimal strategy for low resource settings. Int J Gynecol Cancer 20(5): 862-868, 2010.
    OpenUrlCrossRefPubMed
  12. ↵
    1. Mehlhorn G,
    2. Kage A,
    3. Munzenmayer C,
    4. Benz M,
    5. Koch MC,
    6. Beckmann MW,
    7. Wittenberg T
    : Computer-assisted Diagnosis (CAD) in Colposcopy: Evaluation of a Pilot Study. Anticancer Res 32(12): 5221-5226, 2012.
    OpenUrlAbstract/FREE Full Text
  13. ↵
    1. Papanicolaou GN
    : A New Procedure for Staining Vaginal Smears. Science 95(2469): 438-439, 1942.
    OpenUrlFREE Full Text
  14. ↵
    1. Traut HF,
    2. Papanicolaou GN
    : Cancer of the Uterus: The Vaginal Smear in Its Diagnosis. Cal West Med 59(2): 121-122, 1943.
    OpenUrlPubMed
  15. ↵
    1. Schneider V
    : Cervical cancer screening in Germany. Current status. Pathologe 33(4): 286-292, 2012.
    OpenUrlCrossRefPubMed
  16. ↵
    1. Klug SJ,
    2. Neis KJ,
    3. Harlfinger W,
    4. Malter A,
    5. Konig J,
    6. Spieth S,
    7. Brinkmann-Smetanay F,
    8. Kommoss F,
    9. Weyer V,
    10. Ikenberg H
    : A randomized trial comparing conventional cytology to liquid-based cytology and computer assistance. Int J Cancer Nov 23, 2012.
  17. ↵
    1. Park SY,
    2. Follen M,
    3. Milbourne A,
    4. Rhodes H,
    5. Malpica A,
    6. MacKinnon N,
    7. MacAulay C,
    8. Markey MK,
    9. Richards-Kortum R
    : Automated image analysis of digital colposcopy for the detection of cervical neoplasia. J Biomed Opt 13(1): 014029, 2008.
    OpenUrlCrossRefPubMed
  18. ↵
    1. Fujii T,
    2. Nakamura M,
    3. Kameyama K,
    4. Saito M,
    5. Nishio H,
    6. Ohno A,
    7. Hirao N,
    8. Iwata T,
    9. Tsukazaki K,
    10. Aoki D
    : Digital colposcopy for the diagnosis of cervical adenocarcinoma using a narrow band imaging system. Int J Gynecol Cancer 20(4): 605-610, 2010.
    OpenUrlPubMed
  19. ↵
    1. Doh AS,
    2. Nkele NN,
    3. Achu P,
    4. Essimbi F,
    5. Essame O,
    6. Nkegoum B
    : Visual inspection with acetic acid and cytology as screening methods for cervical lesions in Cameroon. Int J Gynaecol Obstet 89(2): 167-173, 2005.
    OpenUrlCrossRefPubMed
  20. ↵
    1. Griffiths M,
    2. Turner MJ,
    3. Partington CK,
    4. Soutter WP
    : Should smears in a colposcopy clinic be taken after the application of acetic acid? Acta Cytol 33(3): 324-326, 1989.
    OpenUrlPubMed
  21. ↵
    1. Hornemann A,
    2. Husstedt WD,
    3. Hoellen F,
    4. Kamischke A,
    5. Diedrich K,
    6. Bohlmann MK
    : Does acetic acid influence the non-dysplastic Pap smear? Arch Gynecol Obstet 283(6): 1309-1312, 2010.
    OpenUrlPubMed
  22. ↵
    1. Hilgarth M
    : Münchner Nomenklatur II für die gynäkologische Zytodiagnostik. Frauenarzt 39: 392-393, 2001.
    OpenUrl
  23. ↵
    1. Scarinci IC,
    2. Garcia FA,
    3. Kobetz E,
    4. Partridge EE,
    5. Brandt HM,
    6. Bell MC,
    7. Dignan M,
    8. Ma GX,
    9. Daye JL,
    10. Castle PE
    : Cervical cancer prevention: new tools and old barriers. Cancer 116(11): 2531-2542, 2010.
    OpenUrlCrossRefPubMed
  24. ↵
    1. Nguyen HN,
    2. Nordqvist SR
    : The Bethesda system and evaluation of abnormal pap smears. Semin Surg Oncol 16(3): 217-221, 1999.
    OpenUrlCrossRefPubMed
  25. ↵
    1. Kolposkopie AfZ
    : Empfehlungen der AG-CPC zur Kolposkopie bei Erkrankungen des unteren Genitaltraktes der Frau. http://wwwag-cpcde/media/empfehlungenpdf2008.
  26. ↵
    1. Negri G,
    2. Gampenrieder J,
    3. Vigl EE,
    4. Haitel A,
    5. Menia E,
    6. Mian C
    : Human papilloma virus typing at large loop excision of the transformation zone of the cervix uteri. Anticancer Res 23(5b): 4289-4292, 2003.
    OpenUrlPubMed
  27. ↵
    1. Davey DD
    : Quality and liability issues with the Papanicolaou smear: the problem of definition of errors and false-negative smears. Arch Pathol Lab 121(3): 267-269, 1997.
    OpenUrl
  28. ↵
    1. Bollmann M,
    2. Varnai AD,
    3. Griefingholt H,
    4. Bankfalvi A,
    5. Callenberg H,
    6. Speich N,
    7. Schmitt C,
    8. Bollmann R
    : Predicting treatment outcome in cervical diseases using liquid-based cytology, dynamic HPV genotyping and DNA cytometry. Anticancer Res 26(2B): 1439-1446, 2006.
    OpenUrlAbstract/FREE Full Text
  29. ↵
    1. Behtash N,
    2. Mehrdad N
    : Cervical cancer: screening and prevention. Asian Pac J Cancer Prev 7(4): 683-686, 2006.
    OpenUrlPubMed
  30. ↵
    1. Harmanli O,
    2. Jones KA
    . Using lubricant for speculum insertion. Obstet Gynecol 116(2 Pt 1): 415-417, 2010.
    OpenUrlPubMed
  31. ↵
    1. Szurkus DC,
    2. Harrison TA
    : Loop excision for high-grade squamous intraepithelial lesion on cytology: correlation with colposcopic and histologic findings. Am J Obstet Gynecol 188(5): 1180-1182, 2003.
    OpenUrlPubMed
PreviousNext
Back to top

In this issue

Anticancer Research: 33 (3)
Anticancer Research
Vol. 33, Issue 3
March 2013
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Influence of Acetic Acid on a Pap smear of Dysplastic Lesion
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Influence of Acetic Acid on a Pap smear of Dysplastic Lesion
FRIEDERIKE HOELLEN, MICHAEL K. BOHLMANN, JOACHIM BRADE, ACHIM RODY, KLAUS DIEDRICH, WOLF-DIEDRICH HUSSTEDT, AMADEUS HORNEMANN
Anticancer Research Mar 2013, 33 (3) 1125-1130;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Influence of Acetic Acid on a Pap smear of Dysplastic Lesion
FRIEDERIKE HOELLEN, MICHAEL K. BOHLMANN, JOACHIM BRADE, ACHIM RODY, KLAUS DIEDRICH, WOLF-DIEDRICH HUSSTEDT, AMADEUS HORNEMANN
Anticancer Research Mar 2013, 33 (3) 1125-1130;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Conclusion
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Predictive and Prognostic Value of SUOX Expression in Pancreatic Ductal Adenocarcinoma
  • Liberal Application of Portal Vein Embolization for Right Hepatectomy Against Hepatocellular Carcinoma: Strategy to Achieve Zero Mortality for a Damaged Liver
  • Pancreaticoenterostomy With Seromuscular-parenchymal Anastomosis for Prevention of Postoperative Pancreatic Fistula in Distal Pancreatectomy
Show more Clinical Studies

Similar Articles

Keywords

  • Pap smear
  • acetic acid
  • Dysplasia
  • colposcopy
  • Cervical cancer
Anticancer Research

© 2022 Anticancer Research

Powered by HighWire